Boardroom Alpha
Boardroom Alpha
ZSTK · Current Report (Form 8-K) · Filed July 23, 2026

Zerostack Corp — Current Report (Form 8-K)

Form
8-K
Filed
July 23, 2026
Period
Jul 20, 2026
Ticker
ZSTK
Accession
0001062993-26-003811
Boardroom Alpha · Filing insights

ZeroStack closes the private cryptocurrency financing; 0G tokens exchanged for Texas Blocker shares, making Blocker a subsidiary.

About Zerostack Corp
Market cap
$113M
1Y TSR
−87.7%
3Y TSR
−69.2%
Board grade
D
Sector
Financial Services
CEO
Daniel Reis-Faria
Last annual meeting: Dec 19, 2025 · View full Zerostack Corp profile →
ZeroStack Corp.: Form 8-K - Filed by newsfilecorp.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 20, 2026

ZEROSTACK CORP.
(Exact name of registrant as specified in its charter)

Ontario 001-40397 98-1956033
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

2626 Cole Ave, Suite 300
Dallas, Texas, United States 75204
(Address of principal executive offices) (ZIP Code)

Registrant’s telephone number, including area code: (956) 923-4188

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbols   Name of each exchange on which registered
Common Shares, no par value   ZSTK   NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

Emerging growth company ☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.01. Completion of Acquisition or Disposition of Assets.

On July 20, 2026, ZeroStack Corp. (the "Company" or "ZeroStack") announced the closing of the private cryptocurrency financing transaction it previously announced on March 31, 2026 (the "Financing") following shareholder approval of "Proposal 6 - Approval of the Continuance Proposal" set forth in the proxy statement/prospectus (the "Proxy Statement/Prospectus") for the 2026 Annual and Special Meeting of Shareholders (the "Meeting").

Investors in the Financing contributed an aggregate of 142,232,948 native tokens of the Zero Gravity (0G) blockchain (the "0G Tokens") to Texas Blocker Corp. ("Texas Blocker"), a Texas corporation formed by ZeroStack to facilitate the Financing (the "Contribution"), in exchange for an aggregate of 9,104,614 shares of common stock of Texas Blocker (the "Blocker Shares"), which were exchanged on a one-for-one basis for common shares of the Company (the "Common Shares") (the "Exchange").

Concurrent with the closing of the Exchange, Texas Blocker became a wholly-owned subsidiary of ZeroStack and ZeroStack acquired the 142,232,948 0G Tokens Contributed to Texas Blocker in connection with the Financing.

Mr. Michael Heinrich, the Executive Chairman of the Company's board of directors, is the Chief Executive Officer of Zero Gravity Labs Inc. which was an investor in the Contribution and held 4,608,684 Blocker Shares, representing 50.6% of the issued and outstanding Blocker Shares prior to the Exchange. Concurrent with the closing of the Exchange, Zero Gravity received 4,608,864 Common Shares.

The foregoing description of the terms of the Financing does not purport to be complete and is qualified in its entirety by reference to the Company's Current Report on Form 8-K filed on March 31, 2026 including the exhibits filed thereto, which description and text are incorporated by reference herein.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  ZEROSTACK CORP.
     
Date: July 23, 2026 By: /s/ Dany Vaiman
  Name: Dany Vaiman
  Title: Chief Financial Officer



From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Zerostack Corp (ZSTK)

Reference

Frequently asked questions

When did Zerostack Corp file this 8-K?
Zerostack Corp (ZSTK) filed this Current Report (Form 8-K) with the SEC on July 23, 2026. The accession number assigned by EDGAR is 0001062993-26-003811.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
ZeroStack closes the private cryptocurrency financing; 0G tokens exchanged for Texas Blocker shares, making Blocker a subsidiary. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Zerostack Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Zerostack Corp has filed under CIK 1790169, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer